|
1
|
Ferlay J, Colombet M, Soerjomataram I,
Parkin DM, Piñeros M, Znaor A and Bray F: Cancer statistics for the
year 2020: An overview. Int J Cancer. April 5–2021.Epub ahead of
print. View Article : Google Scholar
|
|
2
|
Wang SY, Yang XQ, Wang YX, Shen A, Liang
CC, Huang RJ, Cheng UH, Jian R, An N, Xiao YL, et al:
Overexpression of COX7A1 promotes the resistance of gastric cancer
to oxaliplatin and weakens the efficacy of immunotherapy. Lab
Invest. 104:1020902024. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen Z, Chen Y, Sun Y, Tang L, Zhang L, Hu
Y, He M, Li Z, Cheng S, Yuan J, et al: Predicting gastric cancer
response to anti-HER2 therapy or anti-HER2 combined immunotherapy
based on multi-modal data. Signal Transduct Target Ther. 9:2222024.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen LY, Wang LW, Wen J, Cao JD, Zhou R,
Yang JL, Xiao Y, Su T, Huang Y, Guo Q, et al: RNA-binding protein
YBX3 promotes pparγ-SLC3A2 mediated BCAA metabolism fueling brown
adipogenesis and thermogenesis. Mol Metab. 90:1020532024.
View Article : Google Scholar
|
|
5
|
He S, Valkov E, Cheloufi S and Murn J: The
nexus between RNA-binding proteins and their effectors. Nat Rev
Genet. 24:276–294. 2023. View Article : Google Scholar :
|
|
6
|
Podszywalow-Bartnicka P and Neugebauer KM:
Multiple roles for AU-rich RNA binding proteins in the development
of haematologic malignancies and their resistance to chemotherapy.
RNA Biol. 21:1–17. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li J, Pei M, Xiao W, Liu X, Hong L, Yu Z,
Peng Y, Zhang J, Yang P, Lin J, et al: The HOXD9-mediated
PAXIP1-AS1 regulates gastric cancer progression through PABPC1/PAK1
modulation. Cell Death Dis. 14:3412023. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Choudhury R, Roy SG, Tsai YS, Tripathy A,
Graves LM and Wang Z: The splicing activator DAZAP1 integrates
splicing control into MEK/Erk-regulated cell proliferation and
migration. Nat Commun. 5:30782014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yang HT, Peggie M, Cohen P and Rousseau S:
DAZAP1 interacts via its RNA-recognition motifs with the C-termini
of other RNA-binding proteins. Biochem Biophys Res Commun.
380:705–709. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang J, Ni Z, Zhang Y, Guo Y, Zhai R,
Wang M, Gong Z, Wang M, Zeng F, Gu Z, et al: Dazap1 phase
separation regulates mitochondrial metabolism to facilitate
invasion and metastasis of oral squamous cell carcinoma. Cancer
Res. 84:3818–3833. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sasaki K, Ono M, Takabe K, Suzuki A and
Kurihara Y: Specific intron-dependent loading of DAZAP1 onto the
cox6c transcript suppresses pre-mrna splicing efficacy and induces
cell growth retardation. Gene. 657:1–8. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang Q, Guo Y, Wang W, Liu B, Yang G, Xu
Z, Li J and Liu Z: RNA binding protein DAZAP1 promotes HCC
progression and regulates ferroptosis by interacting with SLC7A11
mRNA. Exp Cell Res. 399:1124532021. View Article : Google Scholar
|
|
13
|
Zhou Y, Huangfu S, Li M, Tang C, Qian J,
Guo M, Zhou Z, Yang Y and Gu C: DAZAP1 facilitates the alternative
splicing of KITLG to promote multiple myeloma cell proliferation
via ERK signaling pathway. Aging. 14:7972–7685. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Platonova N, Lesma E, Basile A, Bignotto
M, Garavelli S, Palano MT, Moschini A, Neri A, Colombo M and
Chiaramonte R: Targeting notch as a therapeutic approach for human
malignancies. Curr Pharm Des. 23:108–134. 2017. View Article : Google Scholar
|
|
15
|
Yeh TS, Wu CW, Hsu KW, Liao WJ, Yang MC,
Li AF, Wang AM, Kuo ML and Chi CW: The activated Notch1 signal
pathway is associated with gastric cancer progression through
cyclooxygenase-2. Cancer Res. 69:5039–5048. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ma H, Li N and Mo Z: Elevated Notch-1
expression promotes the lymph node metastasis of gastric cancer and
the Notch-1-PTEN-ERK1/2 signalling axis promotes the progression of
gastric cancer. Cytokine. 159:1560132022. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Feng P, Chen D, Wang X, Li Y, Li Z, Li B,
Zhang Y, Li W, Zhang J, Ye J, et al: Inhibition of the m(6)A reader
IGF2BP2 as a strategy against T-cell acute lymphoblastic leukemia.
Leukemia. 36:2180–2188. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Guo J, Zhang CD, An JX, Xiao YY, Shao S,
Zhou NM and Dai DQ: Expression of miR-634 in gastric carcinoma and
its effects on proliferation, migration, and invasion of gastric
cancer cells. Cancer Med. 7:776–787. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sugiyama M, Oki E, Nakaji Y, Tsutsumi S,
Ono N, Nakanishi R, Sugiyama M, Nakashima Y, Sonoda H, Ohgaki K, et
al: High expression of the Notch ligand Jagged-1 is associated with
poor prognosis after surgery for colorectal cancer. Cancer Sci.
107:1705–1716. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Qiao X, Ma B, Sun W, Zhang N, Liu Y, Jia L
and Liu C: JAG1 is associated with the prognosis and metastasis in
breast cancer. Sci Rep. 12:219862022. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sunshine HL, Cicchetto AC,
Kaczor-Urbanowicz KE, Ma F, Pi D, Symons C, Turner M, Shukla V,
Christofk HR, Vallim TA and Iruela-Arispe ML: Endothelial Jagged1
levels and distribution are post-transcriptionally controlled by
ZFP36 decay proteins. Cell Rep. 43:1136272024. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gao Y, Cheng X and Han M: ZEB1-activated
Notch1 promotes circulating tumor cell migration and invasion in
lung squamous cell carcinoma. Clin Transl Oncol. 25:817–829. 2023.
View Article : Google Scholar
|
|
23
|
Shao S and Zhao X, Zhang X, Luo M, Zuo X,
Huang S, Wang Y, Gu S and Zhao X: Notch1 signaling regulates the
epithelial-mesenchymal transition and invasion of breast cancer in
a Slug-dependent manner. Mol Cancer. 1:282015. View Article : Google Scholar
|
|
24
|
Paz I, Kosti I, Ares M Jr, Cline M and
Mandel-Gutfreund Y: Rbpmap: A web server for mapping binding sites
of RNA-binding proteins. Nucleic Acids Res. 42:W361–W367. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Vasaikar SV, Deshmukh AP, den Hollander P,
Addanki S, Kuburich NA, Kudaravalli S, Joseph R, Chang JT,
Soundararajan R and Mani SA: Emtome: A resource for pan-cancer
analysis of epithelial-mesenchymal transition genes and signatures.
Br J Cancer. 124:259–269. 2021. View Article : Google Scholar :
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
27
|
Xie R, Wang J, Tang W, Li Y, Peng Y, Zhang
H, Liu G, Huang X, Zhao J, Li A, et al: Rufy3 promotes metastasis
through epithelial-mesenchymal transition in colorectal cancer.
Cancer Lett. 390:30–38. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Peng Y, Zhang P, Huang X, Yan Q, Wu M, Xie
R, Wu Y, Zhang M, Nan Q, Zhao J, et al: Direct regulation of FOXK1
by C-jun promotes proliferation, invasion and metastasis in gastric
cancer cells. Cell Death Dis. 7:e24802016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang P, Tang WM, Zhang H, Li YQ, Peng Y,
Wang J, Liu GN, Huang XT, Zhao JJ, Li G, et al: MiR-646 inhibited
cell proliferation and EMT-induced metastasis by targeting FOXK1 in
gastric cancer. Br J Cancer. 117:525–534. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liu H, Li Z, Zhang L, Zhang M, Liu S, Wang
J, Yang C, Peng Q, Du C and Jiang N: Necroptosis-related prognostic
model for pancreatic carcinoma reveals its invasion and metastasis
potential through hybrid EMT and immune escape. Biomedicines.
11:17382023. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Coelho-Rato LS, Parvanian S, Modi MK and
Eriksson JE: Vimentin at the core of wound healing. Trends Cell
Biol. 34:239–254. 2024. View Article : Google Scholar
|
|
32
|
Ridge KM, Eriksson JE, Pekny M and Goldman
RD: Roles of vimentin in health and disease. Genes Dev. 36:391–407.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Goenka A, Khan F, Verma B, Sinha P, Dmello
CC, Jogalekar MP, Gangadaran P and Ahn BC: Tumor microenvironment
signaling and therapeutics in cancer progression. Cancer Commun
(London). 43:525–561. 2023. View Article : Google Scholar
|
|
34
|
Teoh SL and Das S: Notch signalling
pathways and their importance in the treatment of cancers. Curr
Drug Targets. 19:128–143. 2018. View Article : Google Scholar
|
|
35
|
Hassan WA and Ito T: Identifying specific
Notch1 target proteins in lung carcinoma cells. Histol Histopathol.
36:69–76. 2021.
|
|
36
|
Deng JJ, Li GP, Lu W, Yan Z and Wang Y:
DAZAP1 overexpression promotes growth of HCC cell lines: A primary
study using CEUS. Clin Transl Oncol. 24:1168–1176. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang X, Fan H, Ye X, Hu Y, Xiao Y, Zhang
M, Xu Y, Song J and Luo Y: RNA-binding protein DAZAP1 accelerates
the advancement of pancreatic cancer by inhibiting ferroptosis. Eur
J Med Res. 30:32025. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Li F, Zhao H, Su M, Xie W, Fang Y, Du Y,
Yu Z, Hou L and Tan W: HnRNP-F regulates EMT in bladder cancer by
mediating the stabilization of Snail1 mRNA by binding to its 3'
UTR. EBioMedicine. 45:208–219. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Li F, Xie W, Fang Y, Xie K, Liu W, Hou L
and Tan W: HnRNP-F promotes the proliferation of bladder cancer
cells mediated by PI3K/AKT/FOXO1. J Cancer. 12:281–291. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhang P, Wang W, Xiang H, Zhou Y, Peng Q,
Liu G, Xu ZX and Lu L: DAZAP1 maintains gastric cancer stemness by
inducing mitophagy. JCI Insight. 10:e1754222025. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhou L, Yang Y, Ye Y, Qiao Q, Mi Y, Liu H,
Zheng Y, Wang Y, Liu M and Zhou Y: Notch1 signaling pathway
promotes growth and metastasis of gastric cancer via modulating
CDH5. Aging. 16:11893–11903. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Hodson DJ, Janas ML, Galloway A, Bell SE,
Andrews S, Li CM, Pannell R, Siebel CW, MacDonald HR, De
Keersmaecker K, et al: Deletion of the RNA-binding proteins ZFP36L1
and ZFP36L2 leads to perturbed thymic development and T
lymphoblastic leukemia. Nat Immunol. 11:717–724. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Petkau G, Mitchell TJ, Chakraborty K, Bell
SE, D Angeli V, Matheson L, Turner DJ, Saveliev A, Gizlenci O,
Salerno F, et al: The timing of differentiation and potency of CD8
effector function is set by RNA binding proteins. Nat Commun.
13:22742022. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Shi Q, Xue C, Zeng Y, Yuan X, Chu Q, Jiang
S, Wang J, Zhang Y, Zhu D and Li L: Notch signaling pathway in
cancer: From mechanistic insights to targeted therapies. Signal
Transduct Target Ther. 9:1282024. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Wang L, Cao G, Li W, Chen XW, Xiong SS, Mu
YN, Jiang JF, Yang L, Zhang DR and Cao YW: Expressions and
prognostic values of notch3 and DLL4 in human breast cancer.
Technol Cancer Res Treat. 22:153303382211189842023. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Zhao B, Hu S, Xiao Q, Fan S, Yu X, Li C,
Dong P and Zheng J: Expression of NOTCH receptors and ligands and
prognosis of hepatocellular carcinoma. Biomark Med. 14:1631–1639.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Su H, Wang X, Song J, Wang Y, Zhao Y and
Meng J: Microrna-539 inhibits the progression of Wilms' Tumor
through downregulation of JAG1 and Notch1/3. Cancer Biomark.
24:125–133. 2019. View Article : Google Scholar :
|
